Gut-sparing treatment of urinary tract infection in patients at high risk of Clostridium difficile infection.

Citation data:

The Journal of antimicrobial chemotherapy, ISSN: 1460-2091, Vol: 72, Issue: 2, Page: 522-528

Publication Year:
2017
Usage 78
Abstract Views 64
Link-outs 14
Captures 12
Readers 8
Exports-Saves 4
Social Media 14
Shares, Likes & Comments 12
Tweets 2
Citations 2
Citation Indexes 2
PMID:
27999027
DOI:
10.1093/jac/dkw499
Author(s):
Staley, Christopher; Vaughn, Byron P.; Graiziger, Carolyn T.; Sadowsky, Michael J.; Khoruts, Alexander
Publisher(s):
Oxford University Press (OUP)
Tags:
Pharmacology, Toxicology and Pharmaceutics; Medicine
Most Recent Tweet View All Tweets
article description
Recipients of faecal microbiota transplantation (FMT) in treatment of recurrent Clostridium difficile infection (RCDI) remain at markedly increased risk of re-infection with C. difficile with new antibiotic provocations. Urinary tract infections (UTIs) are common indications for antibiotics in these patients, often resulting in C. difficile re-infection.